Regional Vice President of Sales The Retirement Plan Company
|
Loan & Distribution Specialist AimPoint Pension
|
Defined Benefit Combo Cash Balance Compliance Consultant Loren D. Stark Company (LDSCO)
|
AimPoint Pension
|
Bates & Company, Inc.
|
Compass
|
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
Report of House Committee on Oversight and Reform: Drug Pricing Investigation (PDF)
Committee on Oversight and Government Reform, U.S. House of Representatives Dec. 23, 2021 269 pages. "Although the markets for these products differ, the Committee uncovered common practices that cut across the industry. First, drug companies have raised prices with abandon, especially when they succeed in delaying or blocking competition.... Second, companies have manipulated the patent system and marketing exclusivities granted by the [FDA] to extend their monopolies far longer than lawmakers envisioned when they created these systems.... Third, all the companies the Committee investigated have employed anticompetitive strategies to suppress generic competition.... These practices persist because the highly complex U.S. pharmaceutical market creates perverse incentives to raise prices, and unlike in other countries, drug companies can do so without limitation." |
Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |